1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education
1/2:UHCOP-DLDCCC 联盟:癌症药物发现/开发和教育
基本信息
- 批准号:9789209
- 负责人:
- 金额:$ 27.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdministratorAdvisory CommitteesAfrican AmericanAntineoplastic AgentsApplications GrantsAwarenessCancer BiologyCancer BurdenCancer Center Planning GrantCancer SurvivorshipCessation of lifeChemistryCitiesClinicalClinical TrialsCommunitiesComplementComprehensive Cancer CenterCore FacilityDNADataDevelopmentDiagnosisEducationEducation ProjectsEducation and OutreachEducational CurriculumEnsureEthnic groupExhibitsFundingFutureGenomeGoalsGrantHealthHispanic AmericansIn VitroIncidenceInfrastructureInstitutionJointsLeadLibrariesMalignant NeoplasmsMedical centerMedicineMentorsMethylationMusPatientsPeptoidsPharmacologic SubstancePharmacy FacultyPharmacy facilityPilot ProjectsPopulationPopulation GroupPrevalencePrimary carcinoma of the liver cellsProgram DevelopmentProteinsRecordsResearchResearch PersonnelResearch Project GrantsResistanceStudentsTechnologyTexasTimeTrainingTraining and EducationTranscription CoactivatorUnited StatesUnited States National Institutes of HealthUniversitiesanticancer researchcancer health disparitycancer therapycareercollegedesigndrug developmentdrug discoveryeducation researchexperiencegenome wide methylationgraduate studenthealth disparityhormone therapyin vivo evaluationinhibitor/antagonistinnovationlecturesmalignant breast neoplasmmeetingsmembermethylation patternmultidisciplinarynew technologynoveloutreachprognosticprogramsresearch and developmentsmall molecule inhibitorsuccesstraining opportunitytreatment trialundergraduate researchundergraduate student
项目摘要
SUMMARY OF P20 APPLICATION
Our University of Houston College of Pharmacy (UHCOP)-Dan L. Duncan Comprehensive Cancer Center
(DLDCCC) alliance will develop the infrastructure for a joint drug discovery/development research program to
treat cancers with a health disparity and a joint Cancer Research Education Program (CREP). This alliance is
built on complementary expertise in cutting-edge cancer drug discovery technologies at DLDCCC/Baylor
College of Medicine (BCM) and in development of cancer drugs at UHCOP. The UHCOP is a constituent of the
University of Houston (UH), which is an institution serving underserved health disparity populations (ISUPS).
UHCOP faculty members bring a unique perspective from an ISUPS, which is complemented by a wealth of
pharmaceutical discovery and development experience, existing programs for undergraduate research, and
clinical expertise in working with underserved communities. The DLDCCC, an NCI-designated Comprehensive
Cancer Center, contributes prominent experience and perspective in current cancer treatments and clinical
trials, cutting edge drug discovery technologies and expertise, cancer research core facilities, and existing
undergraduate and graduate training and education programs, including those for patients with cancer health
disparities. UHCOP and BCM are member institutions of the Texas Medical Center, the largest medical center
in the world. The UHCOP/DLDCCC alliance will be led by an Administrative Core, comprised of senior and
experienced investigators in drug discovery/development and cancer biology research. The Internal Advisory
Committee (IAC), composed of experienced and senior cancer research and/or education experts, will guide
the alliance to ensure the successful completion of the proposed goals. The Administrative Core and IAC will
serve as mentors to Co-Leaders of pilot projects, the CREP, and participating early-stage investigators and
underrepresented (UR) trainees. We have selected two co-developed and collaborative Pilot Projects, from a
total of six, to demonstrate the feasibility of the joint infrastructure for drug discovery/development research
investigating cancers with health disparities. These pilot projects have strong potential to launch bi-institutional,
NIH-funded cancer drug discovery/development programs and create state-of-the-art cancer research training
opportunities. We have co-developed a synergistic CREP that will encourage and prepare UR trainees to enter
careers in cancer research. Through research experiences, cancer-specific curricula, and education outreach
efforts to the UR trainees, the CREP will provide a platform for long-term sustained efforts for enlarging the
pipeline of UR trainees in cancer research. The ultimate goal of the UHCOP-DLDCCC alliance will be to
support a multiplier effect by developing joint infrastructure in drug discovery/development, education, and
novel cancer technologies to target the unmet need of tackling cancer health disparities and generate
preliminary data for successful subsequent NCI R-type grant funding.
P20应用综述
我们休斯顿大学药学院(UHCOP)-丹·L·邓肯综合癌症中心
(DLDCCC)联盟将为联合药物发现/开发研究计划开发基础设施,以
治疗有健康差距的癌症和联合癌症研究教育计划(CREP)。这个联盟是
建立在DLDCCC/Bayler在尖端抗癌药物发现技术方面的互补专业知识基础上
医学学院(BCM)和UHCOP的抗癌药物开发。UHCOP是UHCOP的
休斯顿大学(UH),这是一家服务于服务不足的健康差距人群(ISUPS)的机构。
UHCOP教职员工从ISUPS带来了独特的视角,并得到了丰富的
药物发现和开发经验,现有的本科生研究计划,以及
在服务不足的社区工作方面的临床专业知识。DLDCCC,NCI指定的综合体
癌症中心,在当前的癌症治疗和临床中贡献了突出的经验和前景
试验、尖端药物发现技术和专业知识、癌症研究核心设施和现有
本科生和研究生培训和教育方案,包括为癌症健康患者提供的方案
差距。UHCOP和BCM是最大的医疗中心德克萨斯医疗中心的成员机构
在世界上。UHCOP/DLDCCC联盟将由一个行政核心领导,该核心由高级和
在药物发现/开发和癌症生物学研究方面经验丰富的研究人员。内部咨询
由经验丰富的资深癌症研究和/或教育专家组成的委员会(IAC)将指导
联盟以确保圆满完成拟议的目标。行政核心和IAC将
担任试点项目联合领导人、CREP和参与早期调查人员和
任职人数不足(UR)的受训人员。我们选择了两个共同开发和合作的试点项目,
总共六个,以证明药物发现/开发研究联合基础设施的可行性
调查不同健康状况的癌症。这些试点项目有很强的潜力推出双机构、
NIH资助的癌症药物发现/开发计划和创建最先进的癌症研究培训
机遇。我们已经共同开发了一个协同的CREP,它将鼓励和准备UR学员进入
从事癌症研究的职业。通过研究经验、针对癌症的课程和教育推广
为城市培训学员提供一个长期持续努力的平台,以扩大
UR癌症研究实习生的流水线。UHCOP-DLDCCC联盟的最终目标将是
通过在药物发现/开发、教育和发展方面发展联合基础设施,支持倍增效应
新的癌症技术,针对未得到满足的需求,解决癌症健康差距,并产生
成功获得NCI R型赠款资金的初步数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Diana S-L. Chow其他文献
Diana S-L. Chow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Diana S-L. Chow', 18)}}的其他基金
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy
用于 HCC 治疗的具有双药物有效负载的聚合物胶束的 IND 前开发
- 批准号:
10669704 - 财政年份:2022
- 资助金额:
$ 27.88万 - 项目类别:
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy
用于 HCC 治疗的具有双药物有效负载的聚合物胶束的 IND 前开发
- 批准号:
10407228 - 财政年份:2022
- 资助金额:
$ 27.88万 - 项目类别:
2/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education
2/2:UHCOP-DLDCCC 联盟:癌症药物发现/开发和教育
- 批准号:
9789842 - 财政年份:2018
- 资助金额:
$ 27.88万 - 项目类别:
1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education
1/2:UHCOP-DLDCCC 联盟:癌症药物发现/开发和教育
- 批准号:
9789210 - 财政年份:
- 资助金额:
$ 27.88万 - 项目类别:
相似海外基金
EAGER: Toward a Decentralized Cross-administrator Zone Management System: Policy and Technology
EAGER:走向去中心化的跨管理员区域管理系统:政策和技术
- 批准号:
2331936 - 财政年份:2023
- 资助金额:
$ 27.88万 - 项目类别:
Standard Grant
COLLABORATIVE RESEARCH: Social Influence in Eyewitness Identification Procedures: Do Blind Administrator Behaviors Magnify the Effects of Suspect Bias?
合作研究:目击者识别程序中的社会影响:盲目的管理员行为是否会放大嫌疑人偏见的影响?
- 批准号:
2043230 - 财政年份:2021
- 资助金额:
$ 27.88万 - 项目类别:
Continuing Grant
COLLABORATIVE RESEARCH: Social Influence in Eyewitness Identification Procedures: Do Blind Administrator Behaviors Magnify the Effects of Suspect Bias?
合作研究:目击者识别程序中的社会影响:盲目的管理员行为是否会放大嫌疑人偏见的影响?
- 批准号:
2043334 - 财政年份:2021
- 资助金额:
$ 27.88万 - 项目类别:
Continuing Grant
Making of the base for patient safety management skill of visiting nurse administrator by the web conference system
利用网络会议系统构建出诊护士管理者患者安全管理技能基础
- 批准号:
19K10768 - 财政年份:2019
- 资助金额:
$ 27.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of the nursing administrator training program to improve leadership behavior focused on emotional intelligence
制定护理管理人员培训计划,以改善以情商为重点的领导行为
- 批准号:
18K17464 - 财政年份:2018
- 资助金额:
$ 27.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Automated Network Management that Dynamically Reflects Administrator Intent
动态反映管理员意图的自动化网络管理
- 批准号:
18K18038 - 财政年份:2018
- 资助金额:
$ 27.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Administrator support perceived as useful for professional growth by novice psychiatric home-visit nursing staff
新手精神科家访护理人员认为管理员支持对专业成长有用
- 批准号:
17H07005 - 财政年份:2017
- 资助金额:
$ 27.88万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
The Facts and Problems on Management of Public Museums: Validation of Designated Administrator System
公共博物馆管理的事实与问题:指定管理员制度的验证
- 批准号:
17K01212 - 财政年份:2017
- 资助金额:
$ 27.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Study on Transformation of the School Administrator Preparation and Evaluation System in the United States
美国学校管理人员培养与评价体系转型研究
- 批准号:
26780449 - 财政年份:2014
- 资助金额:
$ 27.88万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The Family Court's Supervision of Property Administrator
家庭法院对财产管理人的监督
- 批准号:
26380108 - 财政年份:2014
- 资助金额:
$ 27.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)